Related Experiment Video
Updated: Jan 4, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With
Yi-Yao Chang1,2,3,4, Che-Wei Liao5, Cheng-Hsuan Tsai3
1Graduate Institute of Clinical Medicine National Taiwan University College of Medicine Taipei Taiwan.
Insights
Primary aldosteronism, a common cause of secondary hypertension, is linked to impaired left ventricular diastolic function. Surgical removal of aldosterone-producing tumors improved diastolic function, suggesting aldosterone excess causes this dysfunction.
Area of Science:
- Cardiology
- Endocrinology
- Hypertension Research
Background:
- Primary aldosteronism is the most frequent cause of secondary hypertension.
- It is associated with left ventricular hypertrophy, but its effect on diastolic function remains unclear.
Purpose of the Study:
- To investigate the impact of aldosterone excess on left ventricular (LV) diastolic function.
- To determine if LV diastolic dysfunction in primary aldosteronism is reversible after treatment.
Main Methods:
- Prospective enrollment of 129 patients with aldosterone-producing adenoma and 120 with essential hypertension.
- Echocardiographic analysis, including tissue Doppler imaging, and clinical/biochemical data collection.
- Propensity score matching and reevaluation 1 year post-adrenalectomy for the primary aldosteronism group.
Main Results:
- Propensity-matched patients with aldosterone-producing adenoma exhibited worse LV diastolic function (lower e', higher E/e') than essential hypertension patients.
- LV diastolic function correlated with age, sex, BMI, systolic blood pressure, creatinine, and aldosterone-renin ratio.
- Adrenalectomy significantly improved LV diastolic function (increased e', decreased E/e'), with changes correlated to baseline E/e' and LV mass index.
Conclusions:
- Patients with primary aldosteronism show impaired LV diastolic function compared to essential hypertension, even after matching.
- LV diastolic dysfunction is reversible following adrenalectomy, indicating aldosterone excess induces this condition.
Abstract:
Background Primary aldosteronism is the most common cause of secondary hypertension and is associated with left ventricular hypertrophy. However, whether aldosterone excess is responsible for left ventricular (LV) diastolic dysfunction is unknown. Methods and Results We prospectively enrolled 129 patients with aldosterone-producing adenoma and 120 patients with essential hypertension, and analyzed their clinical, biochemical, and echocardiographic data, including tissue Doppler images. The patients with aldosterone-producing adenoma were reevaluated 1 year after adrenalectomy. After propensity score matching, there were 105 patients in each group. The patients with aldosterone-producing adenoma had worse diastolic function than the patients with essential hypertension, as reflected by lower e' (P<0.001) and higher E/e' (P=0.003). Multivariate analysis showed that LV diastolic function was significantly correlated with age (P<0.001), sex (P<0.001), body mass index (P=0.002), systolic blood pressure (P=0.004), creatinine (P=0.008), and log-transformed aldosterone-renin ratio (P=0.003). After adrenalectomy, the patients with aldosterone-producing adenoma had significant improvements in LV diastolic function as reflected by an increase in e' (P=0.003) and decrease in E/e' (P=0.002). The change in E/e' was independently correlated with baseline E/e' (P<0.001) and change in LV mass index (P=0.006). Conclusions The patients with primary aldosteronism had worse LV diastolic function than the patients with essential hypertension after propensity score matching, and this could be reversed after adrenalectomy, suggesting that aldosterone excess may induce LV diastolic dysfunction.
More Related Videos
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024